Thalidomide-dexamethasone versus Interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.

Authors
Publication date
Publisher
Blackwell Science Limited:PO Box 88, Oxford OX2 0NE United Kingdom:011 44 1865 776868, 011 44 1865 206038, EMAIL: [email protected], INTERNET: http://www.blackwell-science.com, Fax: 011 44 1865 721205

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    IRIS Università Politecnica delle Marche

    redirect
    oaioai:iris.univpm.it:11566/28750
    Last time updated on 11/04/2020